Insider · CIK 0002081359
Lorena Raquel Lerner
Files at KROS (Keros Therapeutics, Inc.). First filing Feb 20, 2026, latest Feb 20, 2026.
Lorena Raquel Lerner files SEC Form 4 as officer at KROS (Keros Therapeutics, Inc.). Since Feb 20, 2026, Lorena Raquel Lerner has reported 0 open-market buys worth $0 and 1 open-market sell worth $63k, the latest filed on Feb 20, 2026.
A track record needs three past buys with six months of prices behind them; Lorena Raquel Lerner has 0, so none is measured yet.
The newest scored trade: sold $63k of KROS on Feb 18, 2026, filed Feb 20, 2026, scored 43 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $63k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KROS: Keros Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | Keros Therapeutics, Inc. | $63k 3,873 shares | -11% | +69% from low-26% from high |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | KROS Keros Therapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Feb 26, 2026 |
| Feb 18, 2026 | KROS Keros Therapeutics, Inc. | SOpen-market sale Common Stock | -3,873 | $16.35 | $63k | 31,127 | Feb 20, 2026 |
Questions about Lorena Raquel Lerner
Answered from the filings on this page, as of the latest one.
Is Lorena Raquel Lerner buying or selling?
In the last 12 months Lorena Raquel Lerner reported 0 open-market buys worth $0 and 1 open-market sell worth $63k on SEC Form 4; the latest was sold $63k of KROS on Feb 18, 2026. Grants, option exercises and tax withholding are not counted.
How did Lorena Raquel Lerner's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lorena Raquel Lerner has 0.
Where does Lorena Raquel Lerner file Form 4?
Lorena Raquel Lerner has filed Form 4 at KROS (Keros Therapeutics, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.